Cabazitaxel Dihydrate
Pharmaceutical standards - Cabazitaxel Dihydrate, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Reference standards of Cabazitaxel Dihydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Cabazitaxel Dihydrate
Catalogue No.:PA 03 4250000
CAS :
1613316-40-7
Molecular Formula : C45H61NO16
Molecular Weight : 871.97

